
Please try another search
Jiangxi Fushine Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of APIs and pharmaceutical intermediates in China and internationally. The company offers penicillin, carbapenem, and other products, as well as intermediates of antiviral drugs. It also provides contract research, development, and manufacturing services, as well as engages in lithium battery electrolyte additives. The company was formerly known as Jingdezhen Fuxiang Pharmaceutical Co., Ltd and changed its name to Jiangxi Fushine Pharmaceutical Co., Ltd. in August 2012. Jiangxi Fushine Pharmaceutical Co., Ltd. was founded in 2002 and is based in Jingdezhen, China.
Name | Age | Since | Title |
---|---|---|---|
Jian Hua Bao | 46 | 2012 | GM & Chairman |
Hai Bin Yang | 52 | 2012 | Chairman of the Supervisory Board |
Dan Ke | 48 | 2020 | Director |
Hong Liu | 64 | 2021 | Independent Director |
Rong Wu Cheng | 55 | 2012 | Director |
Xiaoqing Ji | 51 | 2023 | Independent Director |
Ting Ye | 39 | 2018 | Supervisor |
Huiyue Li | 60 | 2023 | Vice Chairman |
Wei Dong | 47 | 2012 | Manager of the Sales Department & Supervisor |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review